A Philadelphia state court ordered Johnson & Johnson and Bayer AG to pay $27.8 million to an Indiana couple for failing to warn victims of bleeding risks associated with the anticoagulant Xarelto.
The recent court ruling marks the first courtroom victory… Read More
In December, the U.S. Food and Drug Administration (FDA) confirmed that taking the type 2 diabetes drug pioglitazone, also known as Actos, can increase patients' risk of developing bladder cancer.
The FDA announced this conclusion in a drug safety communication,… Read More
After 9,000 lawsuits having been filed against them, Takeda Pharmaceutical Co. has agreed to pay $2.37 billion to resolve claims that the popular diabetes drug Actos causes bladder cancer.
Actos was introduced into the market in 1999 to treat diabetes,and… Read More